| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
In the last 12 months only funds and other entities traded LYCA in the open market: 2 purchases worth about $38.3M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.85M | $189.07M | +2.07M | |
| 10% | 1.39M | $38.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P.54 | 10% Owner | Buy | 25,004 | $25.78 | $644,711.28 | +0.4% | |
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P.54 | 10% Owner | Buy | 2,045,440 | $18.41 | $37,653,863.30 | +42.8% |